Each issue includes summaries in a number of European languages

In the current issue...

Transparency: Rosina Robinson looks at the US FDA's transparency initiative
Labelling: Donald Sherratt summarises the labelling requirements for medical devices in Asia
Adverse events: Elisabethann Wright and Steven Datlof compare and contrast the adverse event reporting requirements in the EU and the USA
Clinical evaluation: Haroon Atchia examines European MEDDEV 2.7.1 Rev 3
Risk management: Mark Leimbeck and Larry Kessler review the market entry requirements for risk management, focusing on FDA and ISO 14971 compliance
Regulatory updates: Australia, Canada, China, Czech Republic, Egypt, Estonia, Europe, France, Greece, Hong Kong, India, Ireland, Italy, Japan, Korea, Libya, New Zealand, Philippines, Singapore, Spain, Switzerland, Tanzania, Uganda, the UK, the United Arab Emirates, and the USA plus the environment, standards and regulatory personnel on the move
Country overview: the medical device regulatory requirements in South Korea
Elemental Essentials: REACH